Neoadjuvant tislelizumab plus chemotherapy among patients with locally advanced cervical cancer: A prospective, single-arm, phase II trial

被引：0
|
作者：
Sheng, Jindong [1 ]
Liu, Wenxin [1 ]
Liu, Ruoyan [1 ]
Liu, Chunyan [1 ]
Wang, Bochang [1 ]
Liu, Xiangyu [1 ]
Xu, Changxiao [1 ]
Fu, Xin [1 ]
Wang, Ke [1 ]
机构：
[1] Tianjin Med Univ, Tianjin, Peoples R China
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [21] Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial
    Zheng, Rong
    Wang, Bi-Si
    Li, Zhihua
    Chi, Pan
    Xu, Benhua
    BMJ OPEN, 2023, 13 (03):
  • [22] Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial.
    Xu, Qin
    Chen, Chuanben
    Sun, Yang
    Huang, Zhangzhou
    Lin, Yibin
    Liu, Jing
    Li, Li
    Li, Zirong
    Pan, Junping
    Chen, Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] Neoadjuvant chemotherapy alone with mFOLFOXIRI in locally advanced rectal cancer: A single-arm phase II study.
    Deng, Yanhong
    Zhang, Jianwei
    Cai, Yue
    Hu, Huabin
    Ling, Jiayu
    Xiao, Jian
    Huang, Meijin
    Kang, Liang
    Wang, Lei
    Lan, Ping
    Wang, Jianping
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [24] Neoadjuvant tislelizumab combined with APF for patients with locally advanced head and neck squamous cell carcinoma: A prospective single-arm clinical trial
    Yan, Jing
    Wang, Kong-cheng
    Yang, Mi
    Gu, Ya-Jun
    Huang, Bin
    Zhu, Yahui
    Sha, Hui-zi
    Zhu, Jing
    Zhu, Chan
    Chen, Dong-sheng
    Qian, Xiao-Yun
    Shen, Xiao-hui
    Chen, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Neoadjuvant sintilimab and apatinib combined with perioperative FLOT chemotherapy for locally advanced gastric cancer: A prospective, single-arm, phase II study
    Zhou Huinian
    Long Bo
    Yu Zeyuan
    Zhu Junmin
    Yang Hanteng
    Luo Changjiang
    Zhang Wenjuan
    Dong Chi
    Guan Xiaoying
    Li Long
    Zhang Gengyuan
    Cao Hongtai
    Chen Shigong
    Zhou Linyan
    He Qichen
    Gan Shiying
    Jiang Xiangyan
    Gu Qianlin
    Wang Keshen
    Shi Wengui
    Qin Long
    Jiao Zuoyi
    中华医学杂志英文版, 2024, 137 (21)
  • [26] A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer
    Kenichiro Toritani
    Jun Watanabe
    Yusuke Suwa
    Kazuya Nakagawa
    Hirokazu Suwa
    Atsushi Ishibe
    Mitsuyoshi Ota
    Chikara Kunisaki
    Takeharu Yamanaka
    Itaru Endo
    International Journal of Colorectal Disease, 2020, 35 : 2197 - 2204
  • [27] Neoadjuvant sintilimab and apatinib combined with perioperative FLOT chemotherapy for locally advanced gastric cancer: A prospective, single-arm, phase II study
    Zhou, Huinian
    Long, Bo
    Yu, Zeyuan
    Zhu, Junmin
    Yang, Hanteng
    Luo, Changjiang
    Zhang, Wenjuan
    Dong, Chi
    Guan, Xiaoying
    Li, Long
    Zhang, Gengyuan
    Cao, Hongtai
    Chen, Shigong
    Zhou, Linyan
    He, Qichen
    Gan, Shiying
    Jiang, Xiangyan
    Gu, Qianlin
    Wang, Keshen
    Shi, Wengui
    Qin, Long
    Jiao, Zuoyi
    CHINESE MEDICAL JOURNAL, 2024, 137 (21) : 2615 - 2617
  • [28] A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer
    Toritani, Kenichiro
    Watanabe, Jun
    Suwa, Yusuke
    Nakagawa, Kazuya
    Suwa, Hirokazu
    Ishibe, Atsushi
    Ota, Mitsuyoshi
    Kunisaki, Chikara
    Yamanaka, Takeharu
    Endo, Itaru
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (12) : 2197 - 2204
  • [29] Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
    Yang, Jinsong
    Huang, Ai
    Yang, Kunyu
    Jiang, Ke
    BMC CANCER, 2023, 23 (01)
  • [30] Neoadjuvant Chemoradiotherapy plus Sequential Tislelizumab Followed by Surgery for Esophageal Carcinoma (CRISEC study): A Prospective, Single-Arm, Phase II Trial
    Yang, J.
    Zhang, Z.
    Wu, B.
    Liu, C.
    Qin, Y.
    Wen, L.
    Wei, J.
    Xiao, G.
    Xing, S.
    Qu, Y.
    Huang, L.
    Wang, X.
    Wang, B.
    Zuo, Z.
    Can, F.
    Jiang, K.
    Yang, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E502 - E502
12345